Synapse - Hematologic Malignancies, Division of

Search Within

Hematologic Malignancies, Division of

Results (13375)

Tazemetostat in combination with lenalidomide and rituximab in patients with relapsed/refractory follicular lymphoma: Updated phase 1b results of SYMPHONY-1 with 22.5 months follow-up

Meeting Abstract

Salles, G.; Park, S. I.; Phillips, T. J.; Amengual, J. E.; Andorsky, D. J.; Campbell, P.; McKay, P.; Leonard, J. P.; Chen, Y. X.; Chen, J. D.; more...
Blood (2023)

Fulltext@MSK | Save

Deciphering the clinical benefit of Pola-R-CHP versus R-CHOP in different genetic subtypes beyond cell of origin in the POLARIX study

Meeting Abstract

Morschhauser, F.; Leung, W.; Raghavan, V.; Lenz, G.; Jardin, F.; Herrera, A. F.; Sehn, L. H.; Sharman, J. P.; Flowers, C. R.; Friedberg, J. W.; more...
Blood (2023)

Fulltext@MSK | Save

Strategies to develop anti-KIR mab lacutamab in patients with peripheral T-cell lymphoma: Preliminary monotherapy clinical data and pre-clinical combinability data

Meeting Abstract

Iyer, S. P.; Ayyappan, S. R.; Greenwell, I. B.; Kim, W. S.; Lee, S. T.; Kim, J. S.; Lee, W. S.; Jeon, Y.; Johnson, W.; Dave, U. P.; more...
Blood (2023)

Fulltext@MSK | Save

Clinical factors associated with cytokine release syndrome and dosing recommendations for restarting elranatamab following an interruption

Meeting Abstract

Niesvizky, R.; Arnulf, B.; Mohty, M.; Nooka, A. K.; Manier, S.; Tomasson, M.; Bahlis, N. J.; Irby, D.; Hibma, J.; Viqueira, A.; more...
Blood (2023)

Fulltext@MSK | Save

A phase 1 study of avapritinib in combination with decitabine in patients with systemic mastocytosis with an associated hematologic neoplasm

Meeting Abstract

Kuykendall, A. T.; Ball, S.; Gotlib, J.; Yi, C. Y. A.; Tashi, T.; Rampal, R. K.; DeAngelo, D. J.; Volpe, V. O.; Pettit, K. M.; Komrokji, R. S.; more...
Blood (2023)

Fulltext@MSK | Save

High-dose targeted radiation with (131)I-apamistamab prior to HCT demonstrated a dose-response for durable complete remission in patients with R/R AML

Meeting Abstract

Litzow, M. R.; Chen, G.; Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Abboud, C. N.; Koshy, N.; Tomlinson, B. K.; Abhyankar, S.; more...
Blood (2023)

Fulltext@MSK | Save

High response rates following point-of-care anti-CD19 CAR T-cell therapy in adults with relapsed/refractory acute B lymphoblastic leukemia

Meeting Abstract

Fried, S.; Danylesko, I.; Marcus, R.; Itzhaki, O.; Yerushalmi, R.; Shem-Tov, N.; Sdayoor, I.; Shouval, R.; Jacoby, E.; Kedmi, M.; more...
Blood (2023)

Fulltext@MSK | Save

Longitudinal assessment of minimal residual disease (MRD) in the ATLAS randomized phase 3 trial of post-transplant treatment with carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide (R) alone in patients with newly diagnosed multiple myeloma (NDMM)

Meeting Abstract

Kubicki, T.; Dytfeld, D.; Wrobel, T.; Jamroziak, K.; Robak, P.; Czyz, J.; Tyczynska, A.; Druzd-Sitek, A.; Giannopoulos, K.; Nowicki, A.; more...
Blood (2023)

Fulltext@MSK | Save

Risk factors of smoldering multiple myeloma: Results from the screened iStopMM study

Meeting Abstract

Thorsteinsdottir, S.; Sverrisdottir, I.; Rögnvaldsson, S.; Ekberg, S.; Hultcrantz, M.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B.; Sigurdardottir, M.; Thorsteinsdottir, I.; more...
Blood (2023)

Fulltext@MSK | Save

Pre-treatment pulmonary assessment have limited utility in B-cell lymphoma patients treated with autologous anti-CD19 CAR T-cell therapy

Meeting Abstract

Sdayoor, I.; Shouval, R.; Fried, S.; Marcus, R.; Danylesko, I.; Yerushalmi, R.; Shem-Tov, N.; Itzhaki, O.; Jacoby, E.; Kedmi, M.; more...
Blood (2023)

Fulltext@MSK | Save